Copyright
©The Author(s) 2025.
World J Clin Pediatr. Jun 9, 2025; 14(2): 100614
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.100614
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.100614
Table 2 Baseline characteristics regarding type of prescribed drug, n (%)
Baseline characteristics regarding type of prescribed drug | Count | |
Antihistamines | Yes | 65 (32.5) |
No | 135 (67.5) | |
Family of antihistamines | First-generation antihistaminic | 17 (8.5) |
Second-generation antihistaminic | 48 (24.0) | |
No | 135 (67.5) | |
Oral nasal decongestant | Yes | 97 (48.5) |
No | 103 (51.5) | |
Type of oral nasal decongestant | Oral nasal decongestant containing pseudoephedrine | 70 (72.2) |
Containing phenylephrine | 26 (26.8) | |
Containing phenylpropanolamine | 1 (1.0) | |
Antitussive medicine | No | 139 (69.5) |
Yes | 61 (30.5) | |
Antipyretic medicine | Yes | 170 (85.0) |
No | 30 (15.0) | |
Type of antipyretics | Paracetamol | 39 (22.8) |
Ibuprofen | 82 (48.0) | |
Diclofenac Na/K | 25 (14.6) | |
Combinations | 25 (14.6) | |
Route of administration of antibiotics | Orally | 74 (37.0) |
Injection | 21 (10.5) | |
Both | 21 (10.5) | |
No | 84 (42.0) | |
Laboratory investigations: Complete blood count and C-reactive protein | Not done | 56 (28.0) |
Done | 144 (72.0) |
- Citation: Kamal AF, Abdelaziz EA, Fahim VF, Saad MH, Badr M. Drug prescribing pattern in upper respiratory tract infections among the pediatric population attending outpatient clinics in pediatric hospitals. World J Clin Pediatr 2025; 14(2): 100614
- URL: https://www.wjgnet.com/2219-2808/full/v14/i2/100614.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i2.100614